ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2097

HLA-B27 Expression Profoundly Shapes the Host-Microbiota Metabolome

Mark Asquith1, Patrick Stauffer2, Sean Davin3, Stephen R. Planck4, Phoebe Lin5 and James T. Rosenbaum6, 1OHSU, Portland, OR, 2Oregon Health & Science University, Portland, OR, 3Oregon Health and Science University, Portland, OR, 4Casey Eye Institute, Oregon Health & Science University, Portland, OR, 5Casey Eye Institute, Oregon Health and Science University, Portland, OR, 6Devers Eye Institute, Legacy Hospital system, Portland, OR

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: metabolomics, microbiome and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Genetics, Genomics and Proteomics

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: The intestinal microbiota plays a pivotal role in both host fitness and disease. Increasing evidence implicates microbial metabolites in the modulation of host immunity in both the gut and the periphery. In this study we used the HLA-B27 transgenic rat model of spondylarthropathy (SpA) to test the hypothesis that HLA-B27, a key SpA risk allele, impacts the host-microbiota metabolome and this may contribute to B27-associated spondylarthropathy.

Methods: We used ultra performance liquid chromatography – tandem mass spectrometry (UPLC-MS/MS) to analyze the metabolic profiles of intestinal contents collected from Fischer HLA-B27/β2m rats and WT controls. Samples were collected at two time points, at 6 weeks of age and at 16 wks. These time points were chosen since they represent time points prior to and subsequent to the development of B27-associated inflammation. Intestinal dysbiosis in this study was analyzed using 16s rRNA sequencing and phyla/species-specific qRT-PCR primers.

                For functional studies, microbial metabolities (short chain fatty acids) were administered p.o. in drinking water. Animals were treated for 10 weeks, with treatment beginning at 6 wks. The development of HLA-B27-associated inflammatory sequelae was analyzed longitudinally and at necropsy. Inflammatory cytokine expression was determined in intestinal tissue by RNA extraction and qRT-PCR.

Results: UPLC-MS/MS analysis detected the presence of 582 host and microbial metabolites. Changes in metabolites related to energetics, inflammation, redox homeostasis and the microbiome were observed at both time points examined. Microbial metabolites of amino acids and of dietary components were strongly impacted by HLA-B27 expression. Medium chain fatty acids (MCFAs) and short chain fatty acids (SCFAs) were globally dysregulated in HLA-B27+ animals. Moreover, 16s analysis of gut microbiota community structure revealed HLA-B27 expression was associated in a marked loss of SCFA-producing Clostridial spp. Strikingly, administration of SCFA propionate led to a significant attenuation of B27-dependent inflammation.

Conclusion: To our knowledge this is the first study to report that expression of SpA-susceptibility allele HLA-B27 profoundly impacts the host-microbiota metabolome. Of the many B27-dependent changes to both host and microbiota metabolic profiles, loss of medium and short chain fatty acids were amongst the most pronounced. SCFAs are a fermentation product of dietary fiber and HLA-B27 expression was associated with reduced colonization by multiple SCFA-producing bacteria. The successful attenuation of B27-dependent spondylarthropathy by targeting these microbial metabolites highlights the translational potential of metabolomic profiling of the intestinal microbiota. These data strongly support further studies of the host-microbiota metabolome in SpA patient populations.


Disclosure: M. Asquith, None; P. Stauffer, None; S. Davin, None; S. R. Planck, None; P. Lin, None; J. T. Rosenbaum, None.

To cite this abstract in AMA style:

Asquith M, Stauffer P, Davin S, Planck SR, Lin P, Rosenbaum JT. HLA-B27 Expression Profoundly Shapes the Host-Microbiota Metabolome [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/hla-b27-expression-profoundly-shapes-the-host-microbiota-metabolome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hla-b27-expression-profoundly-shapes-the-host-microbiota-metabolome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology